How many patents does
Merrimack Pharmaceuticals have?
patents
899
families
101
granted
133
applications
766
US
209
WO
112
EP
88
JP
45
CN
45
KR
44
RoW
356
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Merrimack Pharmaceuticals
Top ten assignees appearing on patents
2009 - 2018
2009
| merrimack pharmaceuticals | 18 |
2018
| merrimack pharmaceuticals | 63 |
| ipsen biopharm | 20 |
Merrimack Pharmaceuticals
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| liposomes useful for drug delivery | 58 | 2004 |
| antibodies against erbb3 and uses thereof | 54 | 2007 |
| methods for treating pancreatic cancer using combination therapies comprising liposomal … 🛈 | 49 | 2012 |
| monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies | 42 | 2011 |
| use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers | 33 | 2010 |
| antibodies against epidermal growth factor receptor (egfr) and uses thereof | 31 | 2011 |
| methods and systems for predicting response of cells to a therapeutic agent | 30 | 2008 |
| human serum albumin linkers and conjugates thereof | 25 | 2008 |
| bi-specific fusion proteins | 25 | 2010 |
| antibodies against the ectodomain of erbb3 and uses thereof | 23 | 2009 |